This is a combination of the antiretroviral drug Combivir (a combination of lamivudine and zidovudine (AZT), and Nevirapine (brand name Viramune). This combination may simplify your therapy and reduce the rate of developing resistance to the separate drugs.
Read more...
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat my HIV | 9 |
|
1 | ||||
| Swollen glands | 1 | 0 | |||||
| Other | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
2 | 67% |
|
|
Expense
|
1 | 33% |
|
|
Personal research
|
1 | 33% |
|
|
Side effects too severe
|
1 | 33% |
|
|
Other
|
1 | 33% |
|
See all 3 patients who’ve stopped taking Combivir/Nevirapine
Report created on November 21, 2009.